Previous Close | 1.1100 |
Open | 1.1400 |
Bid | 0.8000 x 1300 |
Ask | 1.6000 x 800 |
Day's Range | 1.0400 - 1.1300 |
52 Week Range | 1.0300 - 1.9500 |
Volume | |
Avg. Volume | 26,244 |
Market Cap | 36.77M |
Beta (5Y Monthly) | 1.97 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0680 |
Earnings Date | Mar 22, 2022 - Mar 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.30 |
HORSHAM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Michael E. Goodman has been named STRATA’s Head of International Sales. In this newly created role, Mr. Goodman will be a key member of STRATA's expanding global commercial leadership team, with oversight of the Company’s commercial and sa
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -40% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
HORSHAM, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue in the first quarter 2022 of $7.0, a 21% increase over the first quarter of 2021Cash, cash equivalents and restricted cash at March 31, 2022 were $10.9 mill